PVLAPalvella Therapeutics, Inc.

$152.35

What is the market doing?

What the tape says about PVLA

Palvella Therapeutics, Inc. is +207% over the past year while the S&P 500 is +20%: 187 points ahead of the market.

+207%

1-year return · S&P 500 +20%

vs 200-day average
+33%

vs 200-day average · a clear uptrend

RSI (14)
49

RSI (14) · neutral

Below its 52-week high
3.3%

Below its 52-week high

2024-08-15$11.79 – $157.51 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$152.35
1 monthS&P 500 −0.30%
−1.5%
1 yearS&P 500 +20%
+207%
5 yearsS&P 500 +85%
−51%
vs 50-day average$140.84
+8.2%
52-week high
$157.51
52-week low
$48.50
Annualised volatility
78%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$850K
Calendar-year price return
YearReturn
2026 (year to date)+46%
2025+772%
2024−18%
2023−82%
2022−72%
2021+51%
2020−31%
2019+36%
2018−65%
2017+437%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan107 of 10+10%
Feb105 of 10+9.5%
Mar104 of 10−0.22%
Apr102 of 10−8.5%
May105 of 10+17%
Jun105 of 10−5.9%
Jul118 of 11+16%
Aug118 of 11+14%
Sep115 of 11−6.0%
Oct103 of 10−4.2%
Nov105 of 10+1.6%
Dec104 of 10−4.8%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.